# Rationale and Design for Shiga Microalbuminuria Reduction Trial

> **NCT00202618** · PHASE4 · UNKNOWN · sponsor: **Shiga University** · enrollment: 160 (—)

## Conditions studied

- Hypertension
- Diabetes Mellitus
- Albuminuria

## Interventions

- **DRUG:** Valsartan
- **DRUG:** Amlodipine

## Key facts

- **NCT ID:** NCT00202618
- **Lead sponsor:** Shiga University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-12
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 160 (—)
- **Last updated:** 2006-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00202618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00202618, "Rationale and Design for Shiga Microalbuminuria Reduction Trial". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00202618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*